Jul 19, 2018
Bioxodes will present up-to-date preclinical data during the annual ISTH SSC meeting on Thursday 19 July 2018 in Dublin.
Abstract presentation number: PB503 - "Ir-CPI: an original inhibitor of thrombosis and thrombosis-associated with cancer"
Abstract presentation number: PB407 - "Ir-CPI, a contact phase inhibitor, provides an effective and safe thromboprotection during extracorporeal circulation with open-heart surgery"
Poster Session #2, Liffey B
"Ir-CPI a New Potent Inhibitor of Thrombosis and Thrombosis Associated with Cancer"
SSC Session, Wicklow Hall 2
19.07.2018, 10:30 - 12:30
Jul 12, 2017
Abstract Title: "Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment"
May 1, 2016
Bioxodes to participate at the ISTH SCC 2016 annual congress.
Jun 1, 2015
Abstract titles :
“Efficacy of a novel contact pathway inhibitor, Ir-CPI, in an extracorporeal membrane oxygenator model”
“Antithrombotic effects of Ir-CPI in an arterio-venous shunt model in the rabbit”
“Evaluation of the effects of a novel contact pathway inhibitor, Ir-CPI, on in vitro platelet function and coagulation”